SARS-CoV-2与SARS-CoV的主要生物学特性差异对研发防治COVID-19药物的启示(6)
[26] JAIN R P， PETTERSSON H I， ZHANG J， et al. Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro[J]. Journal of Medicinal Chemistry， 2004， 47(25)： 6113-6116.[27] ZHOU Y G， FU B Q， ZHENG X H， et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients[J]. National Science Review ......
您现在查看是摘要页，全文长 2663 字符。